Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
It's about waiting for real data that shows AVA6000 will be the new defectorstandard of care for Sarcoma patients and buying in once it's bottomed out, wherever that might be.
If there's a problem or several more rounds of Heights repayments along the way then so be it.
It's not that complicated?
I don't think big pharma 'mop up' shares.
They watch, then they look (at the data - not Phase 1 data) and then they talk (big money).
Right now they're watching.
I'm sure you do prefer to keep your average private.
On an investment bulletin board a heavy loss might be interpreted as you not making good decisions.
Want to know my average?
Oh.
And what was your average, you forgot to mention.
Or what the company haven't said?
They haven't said that they've started the second dose of the 2 week trial 7 months after announcing the trial.
I don't need to prove Avacta's statements wrong, they do that for themselves well enough
Which one?
Any of them more than 1 year ago and you might spot some discrepancies between what was said and what actually happened?
But you're right, what was said 2 weeks ago?
Bang on schedule!
Bet the bank on it.
If that's what happens then excellent.
Will they be able to though if they're still only on phase 1?
Are they likely to finish on dose escalation 2?
Or might you be wrong about being 'well ahead of schedule?'
Perhaps.
Oh, and what phase of the two week trial are they on 7 months after they announced it.
You forgot to mention it.
Again!
'Well ahead of schedule on all projects'
What a fool you made me look!
Sorry ICE but I will be.
Sold after science day.
Can get back in whenever the tide turns for multiples of what I had before.
Of course it might not work out as planned.
In which case I won't.
Win:Win!
ICE has got it all worked out though.
1) It works.
2) FDA Orphan drugs status granted.
3) We're rich!
£2.50 within 12 - 18 months.
Hmmm.
You're using company forecasts for your timelines?
Good luck with that!
I know ICE.
You made a idiot of me too when I challenged your assertion that 'all Avacta's projects are well ahead of schedule'.
I know you did because that's what you posted
Did you tell me what dose escalation phase of the 2 week trial they're currently on 7 months after announcing it?
No thought not.
And just out of interest what's your average buy price?
Ouch?
Because PL he's looking at what will maxamise the Market Cap over the next 5 - 10 years.
Most are looking at boosting th SP 30p by Q3.
Align your investment with Dr Smith's timelines (not ICE's) any you might well get rich.
But timing your buy in will be crucial.
No I'm not ignoring it, you are.
What phase are we on, you chose not to answer.
I'm thinking realistic inflection points are 3 to 6 months away, at the earliest.
I'm looking at the bigger picture right now iCE.
It's the 6 month share price graph.
And over the next 3 to 6 months I think it's going to carry on just doing the same.
Why wouldn't it.
So what phase of dose escalation?
ICE the 2 week trial was supposed to stark Q4 23
On what phase of dosing are we on now? (Mid Q2 24).
The first phase?
You call that 'full steam ahead'?
Contract Loan Notes are in play, the clinical time lines are slipping and the ever falling share price is making the repayments start to hurt.
It is what it is Watching/ICE but simply says 'almost there' and 'one deal...' doesn't strike me as a particularly informed investment decision. It's simply fanciful wishful thinking.
Just go back over your posts, you've been saying the same things for years and been consistently wrong and here you are today continuing to be wrong.
Can't you see that?
'One last push by shorters' Watching?
Can you show me how to do the clown emoji please I feel you deserve it.
This will continue every 3 months until such time as clinical results and news encourages sufficient change in sentiment for folks on the sidelines to start to want to buy back in.
For the time being why would they.
Watch and wait.